Exakte Wirkstoffkennungen und zitierbare Passagen zu Wechselwirkungen, Gegenanzeigen und Nebenwirkungen.
Ein Paarvergleich findet Originalpassagen, die den anderen Wirkstoff wörtlich nennen. Aussagen gelten für das jeweilige Präparat und seine Formulierung. Klassenbegriffe und abweichende Synonyme können fehlen. Kein Treffer bedeutet nicht, dass keine Wechselwirkung besteht.
Telmisartan
Concomitant administration of telmisartan and mycophenolate mofetil resulted in an approximately
30% decrease of MPA concentrations. Telmisartan changes MPA’s elimination by enhancing
PPAR gamma (peroxisome proliferator-activated receptor gamma) expression, which in turn results in
an enhanced uridine diphosphate glucuronyltransferase isoform 1A9 (UGT1A9) expression and
activity. When comparing rates of transplant rejection, rates of graft loss or adverse event profiles
between patients on mycophenolate mofetil with and without concomitant telmisartan medicine, no
clinical consequences of the pharmacokinetic drug-drug interaction were seen.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
29
Telmisartan
Concomitant administration of telmisartan and mycophenolate mofetil resulted in an approximately
30% decrease of MPA concentrations. Telmisartan changes MPA’s elimination by enhancing
PPAR gamma (peroxisome proliferator-activated receptor gamma) expression, which in turn results in
an enhanced uridine diphosphate glucuronyltransferase isoform 1A9 (UGT1A9) expression and
activity. When comparing rates of transplant rejection, rates of graft loss or adverse event profiles
between patients on mycophenolate mofetil with and without concomitant telmisartan medicine, no
clinical consequences of the pharmacokinetic drug-drug interaction were seen.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Telmisartan
Concomitant administration of telmisartan and mycophenolate mofetil resulted in an approximately
30% decrease of MPA concentrations. Telmisartan changes MPA’s elimination by enhancing
PPAR gamma (peroxisome proliferator-activated receptor gamma) expression, which in turn results in
an enhanced uridine diphosphate glucuronyltransferase isoform 1A9 (UGT1A9) expression and
activity. When comparing rates of transplant rejection, rates of graft loss or adverse event profiles
between patients on mycophenolate mofetil with and without concomitant telmisartan medicine, no
clinical consequences of the pharmacokinetic drug-drug interaction were seen.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Telmisartan
Concomitant administration of telmisartan and mycophenolate mofetil resulted in an approximately
30% decrease of MPA concentrations. Telmisartan changes MPA’s elimination by enhancing
PPAR gamma (peroxisome proliferator-activated receptor gamma) expression, which in turn results in
an enhanced uridine diphosphate glucuronyltransferase isoform 1A9 (UGT1A9) expression and
activity. When comparing rates of transplant rejection, rates of graft loss or adverse event profiles
between patients on mycophenolate mofetil with and without concomitant telmisartan medicine, no
clinical consequences of the pharmacokinetic drug-drug interaction were seen.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Version 2026-05-07T14:22:00Z · SHA-256 8464b0a5294445d85b3f9b902633989ca6f57af3990241a80eda4979936ba419 · Passage edf51c93df85f88a7d9b81f3070015457979f867f71835966c9c5b5a000ef064 · Zeichen 4691–5351 im Abschnitt
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.